Congress approves $50 Million for Kidney Cancer Research in 2023

As we wind down a year of relentless advocacy, we are thrilled to share some outstanding news: Congress has approved $50 million dollars for kidney cancer research in fiscal year 2023!


To put that number in perspective, as recently as 2016, the number of dollars allocated for kidney cancer research was ZERO. This growth is the direct result of tireless advocacy from the kidney cancer community.


This year, we attended 390 Capitol Hill meetings with over 300 advocates working the Hill. We are grateful to you, our grassroots supporters, our donors and advocates, for helping to make this happen.


You asked Congress to #fundthecure, and with every one of these research dollars, we are one step closer.


On behalf of our patients and caregivers, THANK YOU!

Every meeting ...

... every story ...

... every time you showed up ...

You made a difference.

Thank you!

Twitter  Facebook  Linkedin  Instagram  Youtube  
Are you following us online? Tag @KidneyCAN
in your #kidneycancer posts!

KidneyCAN has launched an online shop for our friends to support our work and raise awareness with KidneyCAN apparel! Wear your KidneyCAN spirit with pride, and know that every penny we receive from your purchase goes toward accelerating cures for kidney cancer!

VISIT SHOP
Our mission is to accelerate cures for kidney cancer. We engage in patient advocacy and power research by supporting government and industry research funding, facilitating research collaborations, and offering direct financial support for clinical and laboratory researchers with promising ideas. Our work is funded by grassroots donors from all over the United States. We can't do this without your support.
Thank you for being part of our grassroots army!
DONATE NOW
KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Program (CDMRP) or KCRP (Kidney Cancer Research Program). KidneyCAN's work is funded entirely through donations.
Twitter  Facebook  Linkedin  Instagram  Youtube